ÂÜÀòÂÒÂ×

Victoria Doseeva is an experienced professional in clinical affairs and translational research, currently serving in Global Clinical Affairs at QIAGEN since May 2021. Previously, Victoria worked as a Consultant for 20/20 GeneSystems, focusing on cancer early detection and business development. Victoria's background includes roles as Associate Director and CAP Laboratory Director at The Henry M. Jackson Foundation, and Director of Diagnostics at 20/20 GeneSystems, where significant advancements in cancer detection were achieved. Early career experience encompasses positions at QIAGEN and Digene Corporation, alongside research roles at IBBR, Georgetown University Medical Center, and the National Institutes of Health. Victoria holds a Ph.D. and Master's degree in Chemistry from Lomonosov Moscow State University.